New radiation strategy aims to shrink prostate cancer further in men already on hormone therapy
NCT ID NCT05457699
First seen Apr 08, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study tests whether adding precise, high-dose radiation to cancer spots seen on scans can help men with metastatic prostate cancer who are already responding to hormone therapy. About 80 men will be randomly assigned to get either standard care or standard care plus this targeted radiation. The goal is to see if more men can achieve very low PSA levels and delay cancer progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CRCHUM
RECRUITINGMontreal, Quebec, H2X 0A9, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.